Organ Recovery Systems is often asked by healthcare professionals to provide information related to the use of machine perfusion in clinical practice. Our clients often ask us:
Can machine preservation close the gap between demand and availability of donor organs by increasing utilization of marginal kidneys?
What are the logistical and practical issues in starting a machine preservation program?
Is it possible to have a national machine preservation program?
Can machine preservation extend cold time to enable transplantation at optimal times, without harming the organ?
What clinical experience exists in machine preservation of livers prior to transplantation?
To help answer these questions and facilitate discussion around key topics on clinical use of machine preservation, we have developed a series of video presentations featuring leading transplant surgeons presenting their own experience of machine preservation and the impact it has on their clinical practice.
Click here to see leading transplant surgeons share their clinical experience:
Dr. A. Osama Gaber – Director of Transplantation and Vice Chairman of Surgery, The Methodist Hospital System, Houston, Texas, USA
The benefits of machine perfusion in DBD kidneys
Dr. Andrew Ready– Consultant Renal and General Surgeon Department of Renal Surgery at the New Queen Elizabeth Hospital Birmingham, UK
Addressing recipient factors: optimising the outcomes post-transplant
Professor Benoit Barrou – Groupe Hospitalier Pitié Salpêtrière, Paris, Head of the Kidney Transplantation Program, Department of Urology and Transplant Surgery, France
Why should kidneys be machine perfused?
Dr. James V. Guarrera – Chief, Div of Liver Transplant and HPB Surgery, Professor of Surgery, Rutgers New Jersey Medical School, Program Director, Liver Transplantation, USAWhy should kidneys be machine perfused?
Reducing early allograft dysfunction and improving outcomes in liver transplantation with hypothermic machine preservation.
Dr. James V. Guarrera, Associate Professor of Surgery, Surgical Director of Adult Liver Transplantation, Columbia University Medical Center/New York Presbyterian Hospital, USA, presents his clinical data on hypothermic machine perfusion of standard criteria and marginal donor livers. He believes the findings show that machine perfusion can reduce preservation-related complications and allow safer use of marginal livers with improved results. Read More ›
Dr. A. Osama Gaber, from Methodist J.C. Walter Jr. Transplant Center Houston, Texas, USA, reviews the published data for machine perfusion in kidney transplantation, as well as data from his own center to explain how he has changed his practice to include routine machine perfusion, as soon as possible after cross clamp. Read More ›
Dr. Ready identifies that patients on the kidney transplant waiting list are increasingly complex, and recipients of kidneys from deceased donors are often treated in the context of emergency care, as opposed to living donor recipients who receive the highest levels of expertise during well-planned, elective surgery. Dr. Ready presents the results of a study at the University of Birmingham that investigated the use of machine perfusion as a means to prolong cold ischemia time to permit improved recipient assessment and to bridge transplants into times when maximum expertise was available. Read More ›
Professor Benoit Barrou, Head of the Kidney Transplantation Program, Department of Urology and Transplant Surgery, Groupe Hospitalier Pitié Salpêtrière, Paris, France, presents his clinical practice of machine perfusion and the national French protocol for machine perfusing all expanded criteria donor (ECD) kidneys. Read More ›
Le Professeur Barrou nous présente son expérience clinique de l’utilisation de la machine à perfusion ainsi que le protocole national Français pour la perfusion machine de tous les reins prélevés sur DCE. Read More ›
France is the first country to officially recommend machine perfusion of DBD-ECD kidneys on a national basis … The process may seem complex, but in practice it is not. Any concerns about the process should not outweigh the benefits for the patients.
Prof. Benoit Barrou, Groupe Hospitalier Pitié Salpêtrière, Paris, Head of the Kidney Transplantation Program, Department of Urology and Transplant Surgery, France